Ameriprise’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.6M | Buy |
1,028,639
+104,843
| +11% | +$4.89M | 0.01% | 874 |
|
|
2025
Q4 | $44.8M | Sell |
923,796
-49,032
| -5% | -$2.43M | 0.01% | 941 |
|
|
2025
Q3 | $45.9M | Buy |
972,828
+137,098
| +16% | +$6.62M | 0.01% | 933 |
|
|
2025
Q2 | $40.4M | Sell |
835,730
-40,103
| -5% | -$2.05M | 0.01% | 973 |
|
|
2025
Q1 | $48.6M | Buy |
875,833
+65,231
| +8% | +$3.53M | 0.01% | 853 |
|
|
2024
Q4 | $39.1M | Buy |
810,602
+153,935
| +23% | +$7.83M | 0.01% | 967 |
|
|
2024
Q3 | $37.8M | Buy |
656,667
+256,871
| +64% | +$13.9M | 0.01% | 980 |
|
|
2024
Q2 | $19.4M | Buy |
399,796
+52,013
| +15% | +$2.51M | 0.01% | 1297 |
|
|
2024
Q1 | $16.9M | Buy |
347,783
+165,714
| +91% | +$8.09M | ﹤0.01% | 1408 |
|
|
2023
Q4 | $9.05M | Sell |
182,069
-25,900
| -12% | -$1.27M | ﹤0.01% | 1867 |
|
|
2023
Q3 | $11.2M | Sell |
207,969
-136,879
| -40% | -$7.3M | ﹤0.01% | 1613 |
|
|
2023
Q2 | $18.6M | Sell |
344,848
-14,247
| -4% | -$767K | 0.01% | 1317 |
|
|
2023
Q1 | $19.6M | Buy |
359,095
+61,696
| +21% | +$3M | 0.01% | 1278 |
|
|
2022
Q4 | $14.4M | Sell |
297,399
-15,238
| -5% | -$669K | ﹤0.01% | 1443 |
|
|
2022
Q3 | $11.9M | Buy |
312,637
+10,922
| +4% | +$487K | ﹤0.01% | 1532 |
|
|
2022
Q2 | $15.1M | Buy |
301,715
+25,703
| +9% | +$1.36M | 0.01% | 1421 |
|
|
2022
Q1 | $14.2M | Buy |
276,012
+23,308
| +9% | +$1.2M | ﹤0.01% | 1617 |
|
|
2021
Q4 | $12.7M | Buy |
252,704
+61,939
| +32% | +$3.06M | ﹤0.01% | 1788 |
|
|
2021
Q3 | $9.2M | Sell |
190,765
-148,175
| -44% | -$7.53M | ﹤0.01% | 1919 |
|
|
2021
Q2 | $17.8M | Buy |
338,940
+30,583
| +10% | +$1.6M | 0.01% | 1439 |
|
|
2021
Q1 | $15.3M | Sell |
308,357
-19,783
| -6% | -$950K | 0.01% | 1545 |
|
|
2020
Q4 | $15.9M | Sell |
328,140
-19,537
| -6% | -$964K | 0.01% | 1399 |
|
|
2020
Q3 | $17.4M | Buy |
347,677
+55,580
| +19% | +$2.86M | 0.01% | 1159 |
|
|
2020
Q2 | $14.9M | Sell |
292,097
-102,436
| -26% | -$4.98M | 0.01% | 1251 |
|
|
2020
Q1 | $17.2M | Buy |
394,533
+176,293
| +81% | +$8.44M | 0.01% | 1029 |
|
|
2019
Q4 | $11M | Buy |
218,240
+8,579
| +4% | +$402K | ﹤0.01% | 1672 |
|
|
2019
Q3 | $9.71M | Sell |
209,661
-3,811
| -2% | -$164K | ﹤0.01% | 1706 |
|
|
2019
Q2 | $9.23M | Buy |
213,472
+29,074
| +16% | +$1.24M | ﹤0.01% | 1799 |
|
|
2019
Q1 | $8.16M | Buy |
184,398
+62,787
| +52% | +$2.69M | ﹤0.01% | 1871 |
|
|
2018
Q4 | $5.28M | Buy |
121,611
+8,957
| +8% | +$395K | ﹤0.01% | 2092 |
|
|
2018
Q3 | $5.03M | Sell |
112,654
-196,924
| -64% | -$8.41M | ﹤0.01% | 2331 |
|
|
2018
Q2 | $12.4M | Buy |
309,578
+44,177
| +17% | +$1.74M | 0.01% | 1566 |
|
|
2018
Q1 | $10.6M | Sell |
265,401
-42,759
| -14% | -$1.78M | ﹤0.01% | 1614 |
|
|
2017
Q4 | $13.3M | Sell |
308,160
-82,187
| -21% | -$3.79M | 0.01% | 1384 |
|
|
2017
Q3 | $19.4M | Sell |
390,347
-71,948
| -16% | -$3.48M | 0.01% | 1054 |
|
|
2017
Q2 | $22.1M | Sell |
462,295
-33,570
| -7% | -$1.6M | 0.01% | 960 |
|
|
2017
Q1 | $22.4M | Buy |
495,865
+36,873
| +8% | +$1.56M | 0.01% | 932 |
|
|
2016
Q4 | $18.6M | Buy |
458,992
+33,441
| +8% | +$1.32M | 0.01% | 1044 |
|
|
2016
Q3 | $16.3M | Buy |
425,551
+165,339
| +64% | +$6.63M | 0.01% | 1061 |
|
|
2016
Q2 | $10.9M | Buy |
260,212
+105,670
| +68% | +$4.33M | 0.01% | 1319 |
|
|
2016
Q1 | $6.21M | Buy |
154,542
+51,150
| +49% | +$2.05M | ﹤0.01% | 1792 |
|
|
2015
Q4 | $4.41M | Sell |
103,392
-11,726
| -10% | -$539K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $5.46M | Buy |
115,118
+6,810
| +6% | +$347K | ﹤0.01% | 1951 |
|
|
2015
Q2 | $5.36M | Sell |
108,308
-25,279
| -19% | -$1.28M | ﹤0.01% | 2099 |
|
|
2015
Q1 | $6.6M | Buy |
133,587
+72,070
| +117% | +$3.45M | ﹤0.01% | 1910 |
|
|
2014
Q4 | $2.8M | Sell |
61,517
-84,607
| -58% | -$4.11M | ﹤0.01% | 2395 |
|
|
2014
Q3 | $8.25M | Sell |
146,124
-44,746
| -23% | -$2.4M | 0.01% | 1646 |
|
|
2014
Q2 | $10.1M | Buy |
190,870
+65,950
| +53% | +$3.5M | 0.01% | 1525 |
|
|
2014
Q1 | $6.53M | Sell |
124,920
-1,855,805
| -94% | -$93.9M | ﹤0.01% | 1850 |
|
|
2013
Q4 | $106M | Buy |
1,980,725
+24,116
| +1% | +$1.24M | 0.06% | 303 |
|
|
2013
Q3 | $99.1M | Sell |
1,956,609
-183,995
| -9% | -$9.36M | 0.07% | 314 |
|
|
2013
Q2 | $110M | Buy |
+2,140,604
| New | +$114M | 0.08% | 294 |
|
Other funds holding SNY
MIP
Ameriprise's SNY Position: Q1 2026 in Review
Ameriprise increased its Sanofi (SNY) stake by 11% in Q1 2026, buying an estimated $4.89M and bringing the position to 1,028,639 shares worth $49.6M. The position accounts for 0.01% of the portfolio, ranked #874.
Ameriprise first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $110M in Q2 2013. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Ameriprise held 1,028,639 shares of Sanofi worth $49.6M as of Q1 2026.
- Ameriprise bought 104,843 Sanofi shares in Q1 2026, an estimated $4.89M.
- Sanofi made up 0.01% of Ameriprise's portfolio in Q1 2026, its #874 holding.
- Ameriprise first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Sanofi position peaked at $110M in Q2 2013.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.